Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|October 10, 2019
Targeting AKT for cancer therapyMaryam Shariati, Funda Meric-BernstamFood Research International (Ottawa, Ont.)|November 4, 2025
Sensory evaluation methods for food products targeting different age groups: A reviewMaryam Shariati, Fateme Asadi Touranlou, Mitra RezaieInflammation|February 27, 2019
Silymarin Restores Regulatory T Cells (Tregs) Function in Multiple Sclerosis (MS) Patients In VitroMaryam Shariati, Vahid Shaygannejad, Faezeh Abbasirad, et al.Iranian Journal of Child Neurology|March 10, 2017
Frequency and Causes of Hypotonia in Neonatal Period with the Gestational Age of More Than 36 Weeks in NICU of Mofid Children Hospital, Tehran, Iran During 2012-2014Nosratollah Seyed Shahabi, Hossain Fakhraee, Mohammad Kazemian, et al.Oncogene|June 10, 2021
Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutationsMaryam Shariati, Kurt W Evans, Xiaofeng Zheng, et al.Cancer Research|February 5, 2013
FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancerBrett G Hollier, Agata A Tinnirello, Steven J Werden, et al.JCO Precision Oncology|July 24, 2018
Survival Outcomes by TP53 Mutation Status in Metastatic Breast CancerFunda Meric-Bernstam, Xiaofeng Zheng, Maryam Shariati, et al.Oncotarget|November 3, 2016
Clinical outcomes based on multigene profiling in metastatic breast cancer patientsReva K Basho, Debora de Melo Gagliato, Naoto T Ueno, et al.Cancer Research|September 14, 2021
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast CancerKurt W Evans, Erkan Yuca, Stephen S Scott, et al.Genome Biology|May 25, 2017
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migrationIsidore Rigoutsos, Sang Kil Lee, Su Youn Nam, et al.Pageof 2